GI Dynamics

company

About

GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

GI Dynamics, Inc., a medical device company, develops therapies for the treatment of type 2 diabetes and related metabolic diseases in the United States. Its products also include EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. The company was founded in 2003 and is based in Lexington, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$52M
GI Dynamics has raised a total of $52M in funding over 2 rounds. Their latest funding was raised on Aug 23, 2019 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 23, 2019 Post-IPO Equity $10M 1 Crystal Amber Detail
Jan 7, 2010 Series Unknown $15M 1 Medtronic Detail
Mar 2, 2009 Series C $15M 2 Detail
May 25, 2004 Series B $12M 2 Cutlass Capital Detail

Investors

Number of Lead Investors
Number of Investors
3
4
GI Dynamics is funded by 4 investors. Crystal Amber and Medtronic are the most recent investors.
Investor Name Lead Investor Funding Round
Crystal Amber Yes Post-IPO Equity
Medtronic Yes Series Unknown
Seedling Enterprises Series C
Cutlass Capital Series C